CASP8 and cancer: Similarly, in a meta-analysis incorporating 11 reports with 27,459 cases and 31,614 controls, Yin, et al. associated the CASP8 -652 5N del polymorphism with reduced overall cancer risk via homozygous, dominant, and recessive models [15].